Combined company to operate as Candid Therapeutics, advancing a leading portfolio of T-cell engager therapeutics for autoimmune diseasesConcurrent significantly oversubscribed and upsized financing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results